H.B. Fuller (NYSE:FUL) PT Raised to $78.00 at Deutsche Bank Aktiengesellschaft

H.B. Fuller (NYSE:FULGet Rating) had its price objective upped by investment analysts at Deutsche Bank Aktiengesellschaft from $72.00 to $78.00 in a report released on Friday, The Fly reports. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 13.29% from the company’s current price.

A number of other equities analysts have also weighed in on FUL. StockNews.com began coverage on H.B. Fuller in a research note on Wednesday, October 12th. They issued a “hold” rating on the stock. Robert W. Baird dropped their price objective on H.B. Fuller from $85.00 to $80.00 and set an “outperform” rating for the company in a report on Friday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $71.25.

H.B. Fuller Stock Performance

H.B. Fuller stock opened at $68.85 on Friday. H.B. Fuller has a 12-month low of $57.36 and a 12-month high of $81.41. The company has a quick ratio of 1.18, a current ratio of 1.93 and a debt-to-equity ratio of 1.19. The business’s 50-day moving average price is $75.23 and its two-hundred day moving average price is $68.58. The stock has a market cap of $3.67 billion, a PE ratio of 19.29 and a beta of 1.54.

Insider Buying and Selling

In other news, EVP Zhiwei Cai sold 2,746 shares of the business’s stock in a transaction dated Wednesday, November 9th. The stock was sold at an average price of $71.91, for a total value of $197,464.86. Following the transaction, the executive vice president now directly owns 28,733 shares in the company, valued at $2,066,190.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, VP Timothy J. Keenan sold 9,154 shares of the company’s stock in a transaction that occurred on Monday, October 31st. The stock was sold at an average price of $69.92, for a total transaction of $640,047.68. Following the transaction, the vice president now owns 22,871 shares of the company’s stock, valued at $1,599,140.32. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Zhiwei Cai sold 2,746 shares of the company’s stock in a transaction that occurred on Wednesday, November 9th. The shares were sold at an average price of $71.91, for a total value of $197,464.86. Following the transaction, the executive vice president now directly owns 28,733 shares in the company, valued at approximately $2,066,190.03. The disclosure for this sale can be found here. Insiders sold 200,357 shares of company stock valued at $14,707,214 over the last 90 days. Company insiders own 4.69% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of FUL. Bank of New York Mellon Corp lifted its holdings in shares of H.B. Fuller by 2.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 617,129 shares of the specialty chemicals company’s stock valued at $37,090,000 after purchasing an additional 17,027 shares during the last quarter. Public Employees Retirement Association of Colorado lifted its stake in H.B. Fuller by 3.3% in the 3rd quarter. Public Employees Retirement Association of Colorado now owns 325,374 shares of the specialty chemicals company’s stock valued at $19,555,000 after buying an additional 10,506 shares in the last quarter. Luminus Management LLC lifted its stake in H.B. Fuller by 109.8% in the 2nd quarter. Luminus Management LLC now owns 107,827 shares of the specialty chemicals company’s stock valued at $6,492,000 after buying an additional 56,427 shares in the last quarter. UBS Asset Management Americas Inc. lifted its stake in H.B. Fuller by 4.9% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 66,538 shares of the specialty chemicals company’s stock worth $4,006,000 after purchasing an additional 3,081 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC lifted its stake in H.B. Fuller by 1.8% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 60,092 shares of the specialty chemicals company’s stock worth $3,618,000 after purchasing an additional 1,090 shares in the last quarter. Institutional investors own 96.53% of the company’s stock.

About H.B. Fuller

(Get Rating)

H.B. Fuller Co engages in the manufacture and marketing of adhesives, sealants, and other specialty chemical products. It operates through the following segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment supplies adhesive products in the assembly, packaging, converting, nonwoven, hygiene, health and beauty, flexible packaging, graphic arts and envelope markets.

Further Reading

The Fly logo

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.